Pregnancy after 35 is more common. Is U.S. health care keeping up?

Sara Toups read countless stories about people who discovered problems later in their pregnancy who, because of abortion bans, couldnt access medical care. She feared that if she discovered any complications, no doctor in Louisiana would be able to help her.

This article was published in partnership with The 19th, a newsroom reporting on gender, politics and policy. Sara Toups thought it was early signs of menopause. Her breasts were sore, her belly bloated with discomfort. She started to wonder if she had missed her period. Shouldnt she have gotten it weeks ago? Toups was 44 … Read more

Ranking Member Cassidy Requests Information from Stakeholders on Improving Americans Access to Gene Therapies | The U.S. Senate Committee on Health, Education, Labor & Pensions

Ranking Member Cassidy Requests Information from Stakeholders on Improving Americans Access to Gene Therapies | The U.S. Senate Committee on Health, Education, Labor & Pensions

WASHINGTON Today, U.S. Senator Bill Cassidy, M.D. (R-LA), ranking member of the Senate Health, Education, Labor, and Pensions (HELP) Committee, requested information from stakeholders on ways to improve and protect access to gene therapies for Americans with ultra-rare diseases. Reports show that by the end of 2034 over one million patients will receive a gene … Read more

Jaypirca (pirtobrutinib) Now Approved by U.S. FDA for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Received at Least Two Lines of Therapy, Including a BTK Inhibitor and a BCL-2 Inhibitor

The first and only non-covalent (reversible) BTK inhibitor, Jaypirca has been shown to extend the benefit of BTK inhibition In the BRUIN Phase 1/2 trial, adult patients with CLL/SLL who have received at least two lines of therapy, including a BTK inhibitor and a BCL-2 inhibitor, achieved an overall response rate of 72%  INDIANAPOLIS, Dec. 1, … Read more